NCT07817160
Pelvic Floor Dysfunction in Pulmonary Systemic Sclerosis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
Minor Trial completed Show 4 more changesShow less
- Final enrollment: 37 participants (planned 67)
- Primary completion date changed from estimate of Sep 20, 2026 to Oct 6, 2026
- Study completion date changed from estimate of Oct 1, 2026 to Oct 6, 2026
- Site details revised
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Pelvic Floor Dysfunction - Pelvic Floor Distress Inventory-20 Total Score
Timeframe: Baseline
Secondary (14)
Pulmonary Function Test - Forced Expiratory Volume in One Second
Pulmonary Function Test - Forced Vital Capacity
Pulmonary Function Test - Diffusing Capacity of the Lungs for Carbon Monoxide
Maximum Inspriratory Pressure
Maximum Expiratory Pressure
Show 9 moreShow less
Functional Exercise Capacity - 6-Minute Walk Test
Trunk Flexor Endurance - McGill Core Endurance Test
Trunk Extensor Endurance - McGill Core Endurance Test
Lateral Trunk Endurance - McGill Core Endurance Test
Cough-Related Quality of Life - Leicester Cough Questionnaire
Modified Medical Research Council Dyspnea Scale
Sexual Function - Arizona Sexual Experiences Scale
Disease-Related Functional Status - Scleroderma Health Assessment Questionnaire
Pelvic Floor Health Knowledge - Pelvic Floor Health Knowledge Test
Arms and interventions
Other: Pelvic Floor Health Knowledge Assessment, Pelvic Floor Dysfunction Assessment, Core Endurance Assessment, Body Composition Assessment, Sexual Function Assessment, Respiratory Function, Functional Exercise Capacity Assessment, Functional Status Assessment
Sites
1 site in 1 country
- Istanbul Faculy of Medicine-Department of Pulmonary MedicineIstanbul, Istanbul, Turkey (Türkiye)